These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 7979291

  • 1. Pharmacokinetics and safety of weekly dapsone and dapsone plus pyrimethamine for prevention of pneumocystis pneumonia.
    Falloon J, Lavelle J, Ogata-Arakaki D, Byrne A, Graziani A, Morgan A, Amantea MA, Ownby K, Polis M, Davey RT.
    Antimicrob Agents Chemother; 1994 Jul; 38(7):1580-7. PubMed ID: 7979291
    [Abstract] [Full Text] [Related]

  • 2. Intermittent trimethoprim-sulfamethoxazole compared with dapsone-pyrimethamine for the simultaneous primary prophylaxis of Pneumocystis pneumonia and toxoplasmosis in patients infected with HIV.
    Podzamczer D, Salazar A, Jiménez J, Consiglio E, Santín M, Casanova A, Rufí G, Gudiol F.
    Ann Intern Med; 1995 May 15; 122(10):755-61. PubMed ID: 7717598
    [Abstract] [Full Text] [Related]

  • 3. Dapsone-pyrimethamine compared with aerosolized pentamidine as primary prophylaxis against Pneumocystis carinii pneumonia and toxoplasmosis in HIV infection. The PRIO Study Group.
    Girard PM, Landman R, Gaudebout C, Olivares R, Saimot AG, Jelazko P, Gaudebout C, Certain A, Boué F, Bouvet E.
    N Engl J Med; 1993 May 27; 328(21):1514-20. PubMed ID: 8479488
    [Abstract] [Full Text] [Related]

  • 4. Once-weekly administration of dapsone/pyrimethamine vs. aerosolized pentamidine as combined prophylaxis for Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus-infected patients.
    Opravil M, Hirschel B, Lazzarin A, Heald A, Pechère M, Rüttimann S, Iten A, von Overbeck J, Oertle D, Praz G.
    Clin Infect Dis; 1995 Mar 27; 20(3):531-41. PubMed ID: 7756472
    [Abstract] [Full Text] [Related]

  • 5. Primary prophylaxis for Pneumocystis carinii pneumonia: a randomized trial comparing cotrimoxazole, aerosolized pentamidine and dapsone plus pyrimethamine.
    Mallolas J, Zamora L, Gatell JM, Miró JM, Vernet E, Valls ME, Soriano E, SanMiguel JG.
    AIDS; 1993 Jan 27; 7(1):59-64. PubMed ID: 8442918
    [Abstract] [Full Text] [Related]

  • 6. Four different regimens for prevention of Pneumocystis carinii pneumonia and toxoplasma encephalitis in HIV-infected patients.
    Tocchetti A, Tambini R, Allegro A, Longoni E, Rinaldi E.
    AIDS; 1994 Feb 27; 8(2):272-4. PubMed ID: 8043236
    [No Abstract] [Full Text] [Related]

  • 7. Thrice-weekly cotrimoxazole is better than weekly dapsone-pyrimethamine for the primary prevention of Pneumocystis carinii pneumonia in HIV-infected patients.
    Podzamczer D, Santín M, Jimenez J, Casanova A, Bolao F, Gudiol GR.
    AIDS; 1993 Apr 27; 7(4):501-6. PubMed ID: 8507417
    [Abstract] [Full Text] [Related]

  • 8. Toxicity and efficacy of daily vs. weekly dapsone for prevention of Pneumocystis carinii pneumonia in children infected with human immunodeficiency virus. ACTG 179 Study Team. AIDS Clinical Trials Group.
    McIntosh K, Cooper E, Xu J, Mirochnick M, Lindsey J, Jacobus D, Mofenson L, Yogev R, Spector SA, Sullivan JL, Sacks H, Kovacs A, Nachman S, Sleasman J, Bonagura V, McNamara J.
    Pediatr Infect Dis J; 1999 May 27; 18(5):432-9. PubMed ID: 10353516
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Levels of dapsone and pyrimethamine in serum during once-weekly dosing for prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis.
    Opravil M, Joos B, Lüthy R.
    Antimicrob Agents Chemother; 1994 May 27; 38(5):1197-9. PubMed ID: 8067765
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A randomized trial of three antipneumocystis agents in patients with advanced human immunodeficiency virus infection. NIAID AIDS Clinical Trials Group.
    Bozzette SA, Finkelstein DM, Spector SA, Frame P, Powderly WG, He W, Phillips L, Craven D, van der Horst C, Feinberg J.
    N Engl J Med; 1995 Mar 16; 332(11):693-9. PubMed ID: 7854375
    [Abstract] [Full Text] [Related]

  • 14. Hepatic and pulmonary pneumocystosis during primary prophylaxis for Pneumocystis carinii pneumonia with dapsone/pyrimethamine.
    Podzamczer D, Martos A, Ferrer I, Santin M, Gudiol F.
    Clin Infect Dis; 1993 Jan 16; 16(1):171. PubMed ID: 8448298
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Low-dose co-trimoxazole, aerosolised pentamidine, or dapsone plus pyrimethamine for prevention of Pneumocystis carinii pneumonia.
    Mallolas J, Zamora L, Gatell JM, Miró JM, Soriano E.
    Lancet; 1991 May 11; 337(8750):1162-3. PubMed ID: 1674036
    [No Abstract] [Full Text] [Related]

  • 19. Randomized trial of dapsone and aerosolized pentamidine for the prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis.
    Torres RA, Barr M, Thorn M, Gregory G, Kiely S, Chanin E, Carlo C, Martin M, Thornton J.
    Am J Med; 1993 Dec 11; 95(6):573-83. PubMed ID: 8018144
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.